Clinical Trial Update: Lp-PLA2 and Coronary Atherosclerosis in Humans [NA]

View source ↗

Summary

Completed clinical trial evaluating the role of Lp-PLA2 in coronary atherosclerosis and endothelial dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis
• Endothelial Dysfunction

Snippet

Sponsor: Mayo Clinic | Conditions: Coronary Atherosclerosis, Endothelial Dysfunction | NA | Status: COMPLETED